Back to Rankings

CATX

Perspective TherapeuticsC
NYSE American / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
Current thesis
Primary-source evidence shows VMT-α-NET remains the core value driver: interim April 2026 data added follow-up, reported a 43% objective response rate in the first 23 Cohort 2 patients, and described the program as well tolerated, while management signaled more data and regulatory engagement this year [#PR-2026-04-20] [#8-K-2026-04-20].
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +13.7.
What can break
Early clinical activity may not hold up as more Cohort 2 and Cohort 3 patients mature, and preliminary responses may not convert into durable or registrationally relevant outcomes [#PR-2026-04-20] [#10-K-2026-03-16].
Momentum
8
Value
41
Sentiment
100
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.25 · Bull $8.50 · Bear $2.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-28 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $12.79
Why
Momentum8 · Δ7d +7.5
Value41 · Δ7d -0.1
Sentiment100 · Δ7d +13.7
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Sentiment · See AI snapshot
Momentum
8
26% active weight
Current posture
7d trendFlat
Δ7d
+7.5
Δ21d
+9.7
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
0.0
Sentiment
100
34% active weight
Current posture
7d trendImproving
Δ7d
+13.7
Δ21d
+0.2
Why this grade

Composite grade C. Momentum 8.0 / Value 41.1 / Sentiment 99.9

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$341M
Beta
1.75
Shares Out
114.05M
P/E (TTM) · Derived
-2.1
P/S (TTM)
188.78
P/FCF (TTM) · Derived
-2.30
Rev YoY
-77.8%
EPS YoY
+0.6%
Gross Margin
-489.8%
Op Margin
-11043.4%
Net Debt
-$141.48M
Current Ratio
8.75
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology